Thus, the deficiency of P4HA3, which functions mainly as a mediator of collagen synthesis [8], consistently reduced tumor malignancy both in vitro and in vivo, suggesting that collagen synthesis pathways and extracellular matrix modification is an important regulator of tumor progression. The gene discussed is P4HA3; the disease is neoplasm.